» Articles » PMID: 28203165

Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients After Curative Resection

Overview
Journal Case Rep Oncol
Publisher Karger
Specialty Oncology
Date 2017 Feb 17
PMID 28203165
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The validity of N classification of the 7th edition of the American Joint Committee on Cancer/Union Internationale contre le Cancer (AJCC/UICC) tumor-node-metastasis (TNM) staging system is still under debate. The purpose of this study was to evaluate the prognostic efficacy of the 7th edition of the AJCC/UICC TNM staging system (focusing on N stage), in comparison with the 6th edition, at a single Eastern institution.

Methods: We analyzed 1,435 patients with gastric cancer who underwent curative resection performed from September 1998 to August 2003 at the Memorial Jin-Pok Kim Korea Gastric Cancer Center. We analyzed the survival rate of the patients according to the AJCC/UICC 6th and 7th editions, and compared each stage, focusing on N stage.

Results: Significant differences in the 5-year survival rates were observed between the 6th and the 7th AJCC/UICC staging system. In the 6th edition staging system, the Kaplan-Meier curves discriminated each N stage significantly. In contrast, there was no difference in terms of survival curves for N stage according to the 7th edition, especially between N1 and N2: the Kaplan-Meier plots of survival curves between N1 (77.0%) and N2 (78.1%) stages overlapped significantly ( < 0.05).

Conclusion: Although the 7th UICC staging system is a more detailed and sophisticated system in the T category, there was no prognostic significance between the pN1 and pN2 stages according to our data. Therefore, we suggest establishing a new UICC staging system taking into consideration the application of the N stage.

References
1.
Ahn J, Jung M, Kim C, Hong M, Chon H, Kim H . Prognosis of pN3 stage gastric cancer. Cancer Res Treat. 2009; 41(2):73-9. PMC: 2731212. DOI: 10.4143/crt.2009.41.2.73. View

2.
Kim J, Lee J, Kim S, Yu H, Yang H . Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer. 2002; 1(2):125-133. DOI: 10.1007/s101200050006. View

3.
Patel M, Rhoads K, Ma Y, Ford J, Visser B, Kunz P . Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?. Ann Surg Oncol. 2012; 20(5):1631-8. DOI: 10.1245/s10434-012-2724-5. View

4.
Zhang J, Zhou Y, Jiang K, Shen Z, Ye Y, Wang S . Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies. Tumour Biol. 2014; 35(9):8525-32. DOI: 10.1007/s13277-014-1848-6. View

5.
Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M . Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy. Gastric Cancer. 2013; 17(1):67-75. DOI: 10.1007/s10120-013-0253-y. View